XML 15 R3.htm IDEA: XBRL DOCUMENT v3.21.2
Unaudited Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 6 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Revenues $ 27,908 $ 21,117 $ 53,328 $ 42,329
Cost of revenues 24,647 15,596 46,698 31,768
Gross margin 3,261 5,521 6,630 10,561
Operating expenses:        
Research and development 2,669 2,719 5,711 5,218
Selling, general and administrative 6,697 5,887 13,838 11,524
Amortization of acquisition-related intangibles 627 121 1,212 242
Change in fair value of contingent consideration (2,430) 0 (2,330) 0
Total operating expenses 7,563 8,727 18,431 16,984
Operating loss (4,302) (3,206) (11,801) (6,423)
Interest income, net 25 161 57 320
Other income (expense), net 24 (476) (40) (646)
Loss before income tax expense (4,253) (3,521) (11,784) (6,749)
Income tax expense (benefit) 181 191 (1,947) 380
Net loss $ (4,434) $ (3,712) $ (9,837) $ (7,129)
Net loss per common share        
Basic (in dollars per share) $ (0.16) $ (0.17) $ (0.36) $ (0.33)
Diluted (in dollars per share) $ (0.16) $ (0.17) $ (0.36) $ (0.33)
Weighted average number of common shares outstanding        
Basic (in shares) 27,252 21,860 27,040 21,775
Diluted (in shares) 27,252 21,860 27,040 21,775